SCHEMBL1343699

SCHEMBL1343699

CN1CCc2cc(-c3cccc4c3-c3cc(F)cc5c3C(C4)N(C)CC5)cc3c2C1Cc1cccc(O)c1-3

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 9/20 0.67
HTR1A P08908 6/20 0.67
DRD1 P21728 6/20 0.67
DRD3 P35462 3/20 0.60
HTR7 P34969 1/20 0.56
KDM4E B2RXH2 4/20 0.54
ALDH1A1 P00352 4/20 0.54
MAPT P10636 4/20 0.54
HPGD P15428 4/20 0.54
TP53 P04637 3/20 0.54
PKM P14618 3/20 0.54
MAPK1 P28482 3/20 0.54
KMT2A Q03164 3/20 0.54
HSD17B10 Q99714 3/20 0.54
LMNA P02545 3/20 0.54
MEN1 O00255 2/20 0.54
CYP1A2 P05177 2/20 0.54
CYP3A4 P08684 2/20 0.54
CYP2C9 P11712 2/20 0.54
MDM2 Q00987 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1347782 0.93 DRD2 (0.75) DRD2HTR1ADRD1DRD3KDM4E
SCHEMBL1346072 0.93 DRD2 (0.75) DRD2HTR1ADRD1DRD3KDM4E
SCHEMBL1346087 0.81 HTR1A (0.77) DRD2HTR1ADRD1DRD3KDM4E
SCHEMBL1346957 0.81 HTR1A (0.77) DRD2HTR1ADRD1DRD3KDM4E
SCHEMBL1348125 0.81 HTR1A (1.00) DRD2HTR1ADRD1DRD3KDM4E
SCHEMBL1348123 0.81 HTR1A (1.00) DRD2HTR1ADRD1DRD3KDM4E
SCHEMBL12877888 0.80 DRD2 (0.75) DRD2HTR1ADRD1DRD3KDM4E
SCHEMBL1346853 0.80 DRD2 (0.78) DRD2HTR1ADRD1DRD3KDM4E
SCHEMBL1345828 0.80 DRD2 (0.78) DRD2HTR1ADRD1DRD3KDM4E
Hydrochloric Acid SCHEMBL9468991 0.80 HTR1A (0.97) DRD2HTR1ADRD1DRD3KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8063060-B2 R(−)-11-hydroxyaporphine derivatives and uses thereof THE MCLEAN HOSPITAL CORPORATION (US) 2011-11-22 US disclosed
US-20100081651-A1 R(-)-11-HYDROXYAPORPHINE DERIVATIVES AND USES THEREOF THE MCLEAN HOSPITAL CORPORATION (US) 2010-04-01 US disclosed
US-7648995-B2 R(—)-11-hydroxyaporphine derivatives and uses thereof THE MCLEAN HOSPITAL CORPORATION (US) 2010-01-19 US disclosed
US-20060040900-A1 R(-)-11-hydroxyaporphine derivatives and uses thereof MCLEAN HOSPITAL CORPORATION, THE 2006-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060040900-A1 R(-)-11-hydroxyaporphine derivatives and uses thereof SNCA, HTR5A, PARK7 DRD2 23/4885HTR1A 5/4885DRD1 34/4885
US-20100081651-A1 R(-)-11-HYDROXYAPORPHINE DERIVATIVES AND USES THEREOF SNCA, HTR5A, HTR3A DRD2 23/4885HTR1A 5/4885DRD1 36/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.